Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin


Creative Commons License

AK G. , Tada Y., Shimada H., METİNTAŞ S. , Ito M., Hiroshima K., ...Daha Fazla

BMC CANCER, cilt.17, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 17
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1186/s12885-017-3209-5
  • Dergi Adı: BMC CANCER

Özet

Background: We evaluated possible diagnostic and prognostic values of serum midkine in malignant pleural mesothelioma in comparison with those of serum mesothelin, a well-established diagnostic biomarker.